Japan· JP-6343438D1026
ノナコグアルファ（遺伝子組換え）
A medicinal product containing ノナコグアルファ（遺伝子組換え）, registered in Japan by ファイザー, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ノナコグアルファ（遺伝子組換え）
- Manufacturer
- ファイザー
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ノナコグアルファ（遺伝子組換え） in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBeneFIX 1000 IUPfizer Europe MA
- SwedenBeneFIX 1000 IE Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- CzechiaBENEFIXPfizer Europe MA EEIG, Bruxelles
- FinlandBenefixPfizer Europe MA EEIG
- IrelandBeneFIX 1000 IU powder and solvent for solution for injectionPfizer Europe MA EEIG
- IcelandBeneFIXPfizer Europe MA EEIG*
- PolandBeneFixPfizer Europe MA EEIG
- FranceBENEFIX 1000 UI, poudre et solvant pour solution injectablePFIZER EUROPE MA EEIG (BELGIQUE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Benefix, Rixubis
- Liechtenstein · Benefix, Rixubis
- Norway · Benefix, Rixubis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/220f8d26-4f99-40b3-83a2-1443ae17498d GET /v1/drugs/220f8d26-4f99-40b3-83a2-1443ae17498d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５００国際単位１瓶（溶解液付）",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "6343438D1026",
"category": "注射薬",
"price_yen": 41693,
"generic_name": "ノナコグアルファ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "6343",
"transitional_expiry": null
}See everything about ノナコグアルファ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.